Crucible Therapeutics

Crucible Therapeutics

Specializing in developing new therapies for ALS (Lou Gehrig's disease), the most common genetic form of MND, and frontotemporal dementia (FTD).

  • Edit
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads